Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Heating Pain Relief

Last content change checked dailysee data sync status

Active ingredients
  • Menthol 10 g/100 mL
  • Methyl Salicylate 18 g/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2026
Label revision date
February 4, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredients
  • Menthol 10 g/100 mL
  • Methyl Salicylate 18 g/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2026
Label revision date
February 4, 2026
Manufacturer
CHEMCO CORPORATION
Registration number
M017
NDC root
49283-579
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Ultra Strength Pain Relief Cream is a topical product designed to provide temporary local relief from minor pain in muscles or joints. This cream can be particularly helpful if you're experiencing discomfort from everyday activities or minor injuries.

While the specific mechanism of action isn't detailed, its formulation is intended to target pain directly at the site of application, making it a convenient option for managing localized pain.

Uses

You can use this medication to help relieve minor pain in your muscles or joints temporarily. It's designed to provide local relief, making it easier for you to manage discomfort in those areas. Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication.

Dosage and Administration

For adults and children over 12 years old, you should apply a small amount of the medication directly to the affected area. Gently massage it in using a circular motion and allow it to set for a few seconds. You can repeat this process as needed, but make sure not to exceed 3 to 4 applications in a single day. After using the medication, remember to wash your hands thoroughly with soap and water to avoid any unwanted contact.

If you have a child under 12 years of age, it’s important to consult a doctor before using this medication to ensure it’s safe and appropriate for them.

What to Avoid

It's important to use this product safely to avoid any potential issues. You should not bandage the area tightly or use it with a heating pad, as this can cause complications. Additionally, make sure to avoid contact with your eyes and mucous membranes, and do not apply the product to wounds or any damaged, broken, or irritated skin. Lastly, keep the treated area away from heat and direct sunlight to ensure the best results.

Side Effects

If you are using this product, it's important to be aware of some potential side effects. You should stop using it and consult a doctor if your condition worsens, if you notice redness, or if irritation develops. Additionally, if your symptoms last more than 7 days, improve and then return shortly after, or if you experience signs of injury like pain, swelling, or blistering at the application site, seek medical advice.

Remember, this product is for external use only. If you have any redness over the affected area before using it, please consult a doctor first.

Warnings and Precautions

This product is intended for external use only. Before using it, you should consult your doctor if you notice any redness in the area you plan to treat. If you accidentally swallow the product, seek medical help or contact a Poison Control Center immediately.

You should stop using the product and call your doctor if your condition worsens, if you notice redness, if irritation develops, or if your symptoms last more than 7 days or return shortly after improvement. Additionally, if you experience any signs of injury, such as pain, swelling, or blistering at the application site, it’s important to seek medical advice.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it’s crucial to seek immediate medical help.

In case of an emergency, call your local emergency services or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it’s important to consult with a healthcare professional before using this medication. They can provide guidance tailored to your specific situation and help you understand any potential risks. Always prioritize your health and the health of your baby by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If you have a child under 12 years old, it's important to consult a doctor before using this medication. This ensures that the treatment is safe and appropriate for their age and health needs. Always prioritize your child's well-being by seeking professional guidance when it comes to their medication.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines, dosage adjustments, or monitoring requirements mentioned for your condition in the provided information. This means that the standard recommendations for medication use may apply to you, but it's always best to consult with your healthcare provider for personalized advice. They can help ensure that any treatment you receive is safe and effective based on your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. Currently, there are no known interactions between this medication and other drugs or laboratory tests. However, your healthcare provider can help ensure that your treatment plan is safe and effective, taking into account your unique health situation. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the best performance of your product, store it in a tightly closed container in a dry place. Keep the temperature between 59°-86° F (15°-30° C), which is considered a controlled room temperature. This helps maintain the product's effectiveness and safety.

When handling the product, make sure to do so in a clean environment to avoid contamination. Always follow any specific instructions provided with the product for safe use and disposal. Taking these precautions will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is Ultra Strength Pain Relief Cream used for?

Ultra Strength Pain Relief Cream is used to aid in the temporary local relief of minor pain in muscles or joints.

How should I apply the cream?

For adults and children over 12 years, apply a small amount to the affected area, massage in circular motion, and let it set for a few seconds. You can repeat this up to 3 to 4 times daily.

What should I do after applying the cream?

After use, wash your hands with soap and water to avoid accidental contact with your eyes or mucous membranes.

Are there any precautions I should take?

Yes, do not bandage tightly, use with a heating pad, or apply to wounds or damaged skin. Avoid exposing the treated area to heat or direct sunlight.

What should I do if I experience an allergic reaction?

If you experience an allergic reaction, discontinue use immediately and consult a doctor.

What should I do if my condition worsens?

Stop using the cream and consult a doctor if your condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days.

Is this cream safe for children under 12?

Children under 12 years of age should consult a doctor before using this cream.

Can I use this cream if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before using this cream.

How should I store the cream?

Store the cream tightly closed in a dry place at a controlled room temperature between 59°-86° F (15°-30° C).

Packaging Info

Below are the non-prescription pack sizes of Heating Pain Relief (methyl salicylate, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Heating Pain Relief.
Details

Drug Information (PDF)

This file contains official product information for Heating Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary local relief of minor pain in muscles or joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, a small amount of the product should be applied to the affected area. The application should be followed by a gentle massage in a circular motion, allowing the product to set for a few seconds. This process may be repeated as necessary, but should not exceed 3 to 4 times daily. It is important to wash hands thoroughly with soap and water after each use to prevent unintended exposure.

For children under 12 years of age, it is recommended to consult a healthcare professional prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

  • Tight bandaging or use with a heating pad is not recommended, as it may exacerbate adverse effects.

  • Contact with eyes and mucous membranes should be avoided to prevent irritation or injury.

  • Application to wounds or damaged, broken, or irritated skin is contraindicated due to the risk of further irritation or infection.

  • Exposure of the treated area to heat or direct sunlight is not advised, as it may lead to increased sensitivity or adverse reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if there is any redness present over the affected area.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are instructed to discontinue use and seek medical advice if any of the following occur: the condition worsens, redness develops, irritation arises, symptoms persist for more than seven days, or if symptoms resolve only to recur within a few days. Additionally, if patients experience signs of injury, such as pain, swelling, or blistering at the site of application, they should stop using the product and consult a healthcare professional.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is important to consult a healthcare professional prior to use if there is any redness over the affected area.

In clinical practice, patients are advised to discontinue use and seek medical advice if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should be vigilant for signs of injury, which may include pain, swelling, or blistering at the site of application, and seek medical attention if these symptoms arise.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Heating Pain Relief (methyl salicylate, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Heating Pain Relief.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive administration of the medication.

Healthcare providers should be aware that symptoms of overdosage may vary depending on the pharmacological properties of the drug and the individual patient's response. In cases where overdosage is suspected, immediate medical evaluation is recommended.

Management of overdosage should include supportive care and symptomatic treatment. Healthcare professionals are advised to monitor the patient closely for any adverse effects and to implement appropriate interventions based on the clinical presentation.

In the event of an overdose, contacting a poison control center or seeking guidance from a medical toxicologist may be beneficial for tailored management strategies. It is crucial to document the incident thoroughly and report any adverse events to the relevant regulatory authorities as per local guidelines.

Continued education on the signs and symptoms of overdosage, as well as the importance of adhering to prescribed dosages, is vital in preventing such occurrences.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Patients should be instructed to stop using the product and consult a doctor if their condition worsens, if they notice any redness, or if irritation develops. It is important to inform patients that they should also stop use and seek medical advice if symptoms persist for more than 7 days or if symptoms clear up only to recur within a few days.

Patients should be cautioned to discontinue use and consult a healthcare professional if they experience any signs of injury, such as pain, swelling, or blistering at the application site. Providers should emphasize the importance of using the product only as directed and advise against tightly bandaging the area or using it in conjunction with a heating pad.

Additionally, patients should be warned to avoid contact with eyes and mucous membranes, and not to apply the product to wounds or any damaged, broken, or irritated skin. In the event of an allergic reaction, patients should be instructed to stop using the product immediately and seek medical attention. Finally, healthcare providers should remind patients to avoid exposing the treated area to heat or direct sunlight.

Storage and Handling

The product is supplied in a tightly closed container to ensure stability and integrity. It should be stored in a dry place at controlled room temperature, specifically between 59°-86° F (15°-30° C). Proper storage conditions are essential to maintain the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Heating Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Heating Pain Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.